Amidst a flurry of big pharma deals, the Muscarinic acetylcholine receptor subtype M4 has emerged as...
This November, we highlight the folate receptor alpha (FRα) as the 'Clovertex Target of the Month'. ...
For October 2023, we have the Human Epidermal growth factor Receptor 3 (HER3) as the 'Clovertex Drug...
September's Clovertex Target of the Month is GPR61 following Pfizer's recent publication concerning ...
In August 2023, the GABAA receptor is highlighted our 'Clovertex Target of the Month' as the drug ta...
From the trenches of World War I to the ongoing battle against obesity, the story of UCP1 is as capt...